Similarly, in vivo experiments also showed that knockdown of METTL16 in T24 cell led to the development of smaller tumors and reduce the sensitivity of bladder tumor to cisplatin chemotherapy in nude mice compared with the control group. The gene discussed is METTL16; the disease is urinary bladder neoplasm.